Resveratrol market unfazed by Pfizer’s null results
The growth in resveratrol in the dietary supplements space is unlikely to be fazed by a null result from pharma giants Pfizer for resveratrol and related compounds, say leading players.
Archives for February 10, 2010
DHA omega-3 may improve chemotherapy outcomes: Study
Supplements of the omega-3 fatty acid docosahexaenoic acid (DHA) may improve outcomes for breast cancer patients undergoing chemotherapy, says a new study from France.
DSHEA needs a rethink: medicine academic
“The time has come for lawmakers to re-evaluate the DSHEA,” is the conclusion of a Johns Hopkins University School of Medicine academic in a recent report published in the Archives of Internal Medicine.